Jan. 20, 2017: Drug-resistant Tuberculosis
Jan. 20, 2017
PHOTO OF THE WEEK
A Lifetime Committed to Eliminating One of the World’s Deadliest Disease
The quest to cure tuberculosis (TB) is more than 15,000 years old. The tubercle baccilus was discovered by Robert Koch, MD, in 1882. From that initial discovery we have made dramatic strides in the diagnosis and treatment of this ancient disease. But it has only been in the past 70 years that we have developed effective anti-TB drugs to treat the nearly 10 million people around the globe who still fall sick to this disease every year… Read blog
XDR-TB is the deadliest and most dangerous strain of tuberculosis
TB Unmasked – Searching for Solutions
US CDC Director Dr. Tom Frieden knows the global TB crisis from firsthand experience. With perspectives from Dr. Frieden, Uvi, Shelly, Susheela and Vivian, we examine the urgent need to protect our healthcare workers from the diseases they work to treat. There is more that we can do now, but the only permanent solution is the creation of an effective TB vaccine. Watch video
Story of the Week
South African Study Provides Compelling New Evidence on Role of Person to Person Transmission in Drug-Resistant TB Epidemics
A joint Emory/CDC/NIH study published this week in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR TB) is spreading primarily from person-to-person in KwaZulu-Natal, South Africa. The study builds on a growing body of evidence showing that person-to-person transmission is a key driver of the spread of drug-resistant TB in some countries with high burden of disease… Read story
On January 22, 2016, CDC activated the Incident Management System and, working through the Emergency Operations Center (EOC), centralized the response to the outbreaks of Zika occurring in the Americas and increased reports of birth defects and Guillain-Barré syndrome in areas affected by Zika. On February 1, 2016, the World Health Organization declared a Public Health Emergency of International Concern (PHEIC) because of clusters of microcephaly and other neurological disorders in some areas affected by Zika. On February 8, 2016, CDC elevated response efforts to a Level 1 activation, the highest response level at the agency.
CDC is working with international public health partners and with state and local health departments to
- Alert healthcare providers and the public about Zika.
- Post travel notices and other travel-related guidance.
- Provide state health laboratories with diagnostic tests.
- Monitor and report cases of Zika, which will helps improve our understanding of how and where Zika is spreading.
Spread of highly drug-resistant tuberculosis sparks concerns
January 18, 2017
Why Is Extensively Drug-Resistant TB On The Rise?
NPR Goats and Soda
January 18, 2017
Tom Frieden, Head Of Atlanta-based CDC, To Resign
January 5, 2017
Medical detectives raced to save a man from a rare, ‘universally lethal’ disease
The Washington Post
December 22, 2016
This free newsletter is sent out regularly by the CDC Center for Global Health. Sign up today to receive these newsletters directly in your inbox!
- Page last reviewed: January 20, 2017
- Page last updated: January 20, 2017
- Content source:
Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.